44 related articles for article (PubMed ID: 35998501)
1. Impact of baseline gadoxetic acid-enhanced liver magnetic resonance and diffusion-weighted imaging in resectable colorectal liver metastases: A prospective, monocentric study.
Moretto R; Borelli B; Boraschi P; Roffi N; Donati F; Antoniotti C; Della Pina C; Colombatto P; Balestri R; Signori S; Gigoni R; Guidoccio F; Volterrani D; Masi G; Cremolini C; Urbani L
Surg Oncol; 2022 Sep; 44():101836. PubMed ID: 35998501
[TBL] [Abstract][Full Text] [Related]
2. Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study.
Görgec B; Hansen I; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bisschops RHC; Bollen TL; Bosscha K; Burgmans MC; Cappendijk V; De Boer MT; D'Hondt M; Edwin B; Gielkens H; Grünhagen DJ; Gillardin P; Gobardhan PD; Hartgrink HH; Horsthuis K; Kok NFM; Kint PAM; Kruimer JWH; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Morone M; Pennings JP; Peringa J; Te Riele WW; Vermaas M; Wicherts D; Willemssen FEJA; Zonderhuis BM; Bossuyt PMM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J;
BMC Cancer; 2021 Oct; 21(1):1116. PubMed ID: 34663243
[TBL] [Abstract][Full Text] [Related]
3. MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial.
Görgec B; Hansen IS; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bosscha K; Burgmans MC; Cappendijk VC; D'Hondt M; Edwin B; van Erkel AR; Gielkens HAJ; Grünhagen DJ; Gobardhan PD; Hartgrink HH; Horsthuis K; Klompenhouwer EG; Kok NFM; Kint PAM; Kuhlmann K; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Meijerink M; Meyer Y; Morone M; Peringa J; Sijberden JP; van Delden OM; van den Bergh JE; Vanhooymissen IJS; Vermaas M; Willemssen FEJA; Dijkgraaf MGW; Bossuyt PM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J;
Lancet Oncol; 2024 Jan; 25(1):137-146. PubMed ID: 38081200
[TBL] [Abstract][Full Text] [Related]
4. Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and
Uutela A; Ovissi A; Hakkarainen A; Ristimäki A; Lundbom N; Kallio R; Soveri LM; Salminen T; Ålgars A; Halonen P; Ristamäki R; Nordin A; Blanco Sequeiros R; Rinta-Kiikka I; Lantto E; Virtanen J; Pääkkö E; Liukkonen E; Saunavaara J; Ryymin P; Lammentausta E; Osterlund P; Isoniemi H;
ESMO Open; 2021 Aug; 6(4):100208. PubMed ID: 34325107
[TBL] [Abstract][Full Text] [Related]
5. Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases.
Kuiper BI; Abu Hilal M; Aldrighetti LA; Björnsson B; D'Hondt M; Dopazo C; Fretland ÅA; Isoniemi H; Philip Jonas J; Kazemier G; Lesurtel M; Primrose J; Schnitzbauer AA; Buffart T; Gruenberger B; Swijnenburg RJ; Gruenberger T
HPB (Oxford); 2024 May; 26(5):639-647. PubMed ID: 38373870
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Performance of Contrast Enhanced CT Alone or in Combination with (Non-)Enhanced MRI for Colorectal Liver Metastasis.
Qiu QS; Zhu K; Wang JH; Chen XS; Wang WT; Dong SY; Sun W; Rao SX
Acad Radiol; 2023 Sep; 30(9):1856-1865. PubMed ID: 36481127
[TBL] [Abstract][Full Text] [Related]
7. The Role of Systemic Therapy in Resectable Colorectal Liver Metastases: Systematic Review and Network Meta-Analysis.
Sonbol MB; Siddiqi R; Uson PLS; Pathak S; Firwana B; Botrus G; Almader-Douglas D; Ahn DH; Borad MJ; Starr J; Jones J; Stucky CC; Smoot R; Riaz IB; Bekaii-Saab T
Oncologist; 2022 Dec; 27(12):1034-1040. PubMed ID: 36239399
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of magnetic resonance imaging for colorectal liver metastasis: A systematic review and meta-analysis.
Mao Y; Chen B; Wang H; Zhang Y; Yi X; Liao W; Zhao L
Sci Rep; 2020 Feb; 10(1):1969. PubMed ID: 32029809
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment.
Wesdorp NJ; Bolhuis K; Roor J; van Waesberghe JTM; van Dieren S; van Amerongen MJ; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
Ann Surg Open; 2021 Dec; 2(4):e103. PubMed ID: 37637880
[TBL] [Abstract][Full Text] [Related]
10. Upfront Surgery versus Neoadjuvant Perioperative Chemotherapy for Resectable Colorectal Liver Metastases: A Machine-Learning Decision Tree to Identify the Best Potential Candidates under a Parenchyma-Sparing Policy.
Famularo S; Milana F; Cimino M; Franchi E; Giuffrida M; Costa G; Procopio F; Donadon M; Torzilli G
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765570
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases.
Araujo RLC; Fonseca LG; Silva RO; Linhares MM; Uson Junior PLS
Hepatobiliary Surg Nutr; 2024 Apr; 13(2):273-292. PubMed ID: 38617479
[TBL] [Abstract][Full Text] [Related]
12. Liver MRI in patients scheduled for local therapy of colorectal liver metastases.
Vernuccio F
Lancet Oncol; 2024 Jan; 25(1):9-10. PubMed ID: 38081199
[No Abstract] [Full Text] [Related]
13. Enhancing Clinical Decision-Making: The Impact of Liver Contrast-enhanced MRI on Local Treatment Plans for Colorectal Liver Metastases.
Lin YM
Radiol Imaging Cancer; 2024 Jan; 6(1):e239023. PubMed ID: 38240670
[No Abstract] [Full Text] [Related]
14. Assessment of the response to systemic treatment of colorectal liver metastases on cross-sectional imaging - a systematic review.
Morawska I; Cieszanowski A
Pol J Radiol; 2023; 88():e512. PubMed ID: 38125815
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for non-resectable colorectal liver metastases.
Aziz H; Sharif S; Gribovskaja-Rupp I; Hemming AW
Hepatobiliary Surg Nutr; 2023 Aug; 12(4):595-597. PubMed ID: 37601003
[No Abstract] [Full Text] [Related]
16. Efficient Health Care: Decreasing MRI Scan Time.
GharehMohammadi F; Sebro RA
Radiol Artif Intell; 2024 May; 6(3):e240174. PubMed ID: 38691009
[No Abstract] [Full Text] [Related]
17. Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience.
Moretto R; Germani MM; Borelli B; Conca V; Rossini D; Boraschi P; Donati F; Urbani L; Lonardi S; Bergamo F; Cerma K; Ramondo G; D'Amico FE; Salvatore L; Valente G; Barbaro B; Giuliante F; Di Maio M; Masi G; Cremolini C
ESMO Open; 2024 Apr; 9(4):102991. PubMed ID: 38631269
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection.
Schnitzer ML; von Münchhausen N; Biechele G; Runtemund J; Grawe F; Geyer T; Kaiser CG; Haag F; Rübenthaler J; Froelich MF
Front Oncol; 2023; 13():1161738. PubMed ID: 37554160
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Outcome of Disappearance or Small Remnants of Colorectal Liver Metastases during First-Line Chemotherapy on Hepatobiliary Contrast-Enhanced and Diffusion-Weighted MR Imaging.
Boraschi P; Moretto R; Donati F; Borelli B; Mercogliano G; Giugliano L; Boccaccino A; Della Pina MC; Colombatto P; Signori S; Masi G; Cremolini C; Urbani L
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190129
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
